Cargando…
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models
The immunosuppressive character of head and neck cancers may explain the relatively low response rates to antibody therapy targeting a tumor antigen, such as cetuximab, and anti-PD-1 checkpoint inhibition. Immunostimulatory agents that overcome tumor-derived inhibitory signals could augment therapeu...
Autores principales: | Gruijs, Mandy, Ganzevles, Sonja H., Stigter-van Walsum, Marijke, van der Mast, Richard, van Ostaijen-ten Dam, Monique M., Tuk, Cornelis W., Schilham, Marco W., Leemans, C. René, Brakenhoff, Ruud H., van Egmond, Marjolein, van de Ven, Rieneke, Bakema, Jantine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541276/ https://www.ncbi.nlm.nih.gov/pubmed/34681717 http://dx.doi.org/10.3390/ijms222011057 |
Ejemplares similares
-
Mechanisms of colorectal liver metastasis development
por: Shasha, Tal, et al.
Publicado: (2022) -
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck
por: de Boer, D. Vicky, et al.
Publicado: (2017) -
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death
por: van Harten, Anne M., et al.
Publicado: (2019) -
At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
por: Wondergem, Niels E., et al.
Publicado: (2021) -
Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA‐induced human neutrophil activation and migration
por: Heineke, Marieke H., et al.
Publicado: (2017)